Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine A Janeway

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2021
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group ReportPatrick J Leavey, Nadia N Laack, Mark D Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Cancer Screening Recommendations for Individuals with Li-Fraumeni SyndromeChristian P Kratz, Maria Isabel Achatz, Laurence Brugières, et al.
Journal of the National Cancer Institute|May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CSusan N Chi, Joanna S Yi, P Mickey Williams, et al.
Cancer Medicine|June 2, 2023
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumorsRaja Shaikh, Brent R Weil, Christopher B Weldon, et al.
The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.
Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.
Pediatric Blood & Cancer|July 16, 2020
Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research useR Seth Pinches, Catherine M Clinton, Abigail Ward, et al.
JCO Precision Oncology|October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialSarah Scollon, Sharon E Plon, Steven Joffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Julia Glade-Bender, et al.
NPJ Precision Oncology|May 5, 2026
An international framework for clinical translation of molecular classifiers in osteosarcomaAmanda E Marinoff, Michaela Nathrath, David S Shulman, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2021
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group ReportPatrick J Leavey, Nadia N Laack, Mark D Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Cancer Screening Recommendations for Individuals with Li-Fraumeni SyndromeChristian P Kratz, Maria Isabel Achatz, Laurence Brugières, et al.
Journal of the National Cancer Institute|May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CSusan N Chi, Joanna S Yi, P Mickey Williams, et al.
Cancer Medicine|June 2, 2023
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumorsRaja Shaikh, Brent R Weil, Christopher B Weldon, et al.
The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.
Cancer Research|January 11, 2017
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor SpectraJuliann Chmielecki, Mark Bailey, Jie He, et al.
Pediatric Blood & Cancer|July 16, 2020
Making the most of small samples: Optimization of tissue allocation of pediatric solid tumors for clinical and research useR Seth Pinches, Catherine M Clinton, Abigail Ward, et al.
JCO Precision Oncology|October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialSarah Scollon, Sharon E Plon, Steven Joffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Julia Glade-Bender, et al.
NPJ Precision Oncology|May 5, 2026
An international framework for clinical translation of molecular classifiers in osteosarcomaAmanda E Marinoff, Michaela Nathrath, David S Shulman, et al.
Pageof 15